Advertisement Pharmaceutical Business review - Page 664 of 5261 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 16, 2026

Immunic secures $400m fund to support commercial-stage development

Immunic has announced an oversubscribed private placement of up to $400m, strengthening its move from an R&D-focused organisation into a commercial-stage entity.

Continue
The proceeds will be used for completing ongoing Phase III ENSURE trials for vidofludimus calcium in RMS. Credit: Gorodenkoff / Shutterstock.com.
February 16, 2026

FDA issues complete response letter to Disc Medicine’s bitopertin NDA

Disc expects issues raised by the FDA can be addressed through APOLLO study data. Credit: Alexander Raths / Shutterstock.com.
February 13, 2026

Ampersand Capital acquires Purna Pharmaceuticals

The MedPharm-Purna partnership could become a preferred trans-Atlantic provider for development of topical and transdermal pharmaceutical products. Credit: Krisana Antharith / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Amgen receives EC approval for Uplizna in generalised myasthenia gravis
  2. Citius Oncology and Uniphar sign European distribution deal for Lymphir
  3. MSD receives FDA approval for Keytruda combo to treat ovarian cancer
  4. THX Pharma and Biocodex sign licensing deal for Batten-1 and TX01 drugs
  5. Insilico and CMS launch drug discovery collaborations for CNS diseases

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography